U.S. Semiconductors Stock News

NasdaqCM:MNSB
NasdaqCM:MNSBBanks

MainStreet Bancshares (MNSB) Net Interest Margin Resilience Tests Bullish Narratives In Q1 2026

MainStreet Bancshares (MNSB) has followed up its move back into profitability with Q1 2026 results that sit against a recent run of steady quarterly revenue and earnings, capped most recently by Q4 2025 revenue of about US$17.7 million and basic EPS of US$0.46 on net income of US$3.5 million. Over the last few quarters, the company has seen total revenue move from US$13.3 million in Q3 2024 to US$17.4 million in Q1 2025 and then to US$17.7 million in Q4 2025. Over the same period, quarterly...
NasdaqGS:COO
NasdaqGS:COOMedical Equipment

Is Cooper Companies (COO) Now Attractive After Recent Share Price Weakness?

If you are wondering whether Cooper Companies is starting to look better value after a weaker share price, this article walks through the key numbers that matter to you. The stock last closed at US$69.46, with returns of a 3.1% decline over 7 days, a 0.7% decline over 30 days, a 14.4% decline year to date, and an 11.7% decline over 1 year. These moves may have changed how some investors view its risk and opportunity profile. Recent coverage has focused on Cooper Companies within the broader...
NasdaqGM:ISTR
NasdaqGM:ISTRBanks

Investar Holding (ISTR) Rising Net Interest Margin Reinforces Bullish Profitability Narratives

Investar Holding (ISTR) has just put fresh numbers on the table for Q1 2026, with recent quarters showing total revenue stepping from US$20.2 million in Q4 2024 to US$23.2 million in Q4 2025 and quarterly EPS ranging between about US$0.46 and US$0.64 over 2025. Over the same period, trailing twelve month EPS moved from US$2.06 to US$2.22 while revenue on this basis went from US$83.2 million to US$93.3 million, giving investors a clear line of sight on how the top line and per share earnings...
NYSE:RNR
NYSE:RNRInsurance

RenaissanceRe Holdings (RNR) Valuation Check After Recent Share Price Momentum

RenaissanceRe Holdings (RNR) continues to draw attention after recent trading, with the stock closing at US$312.80. Investors are weighing this price against the company’s recent returns and its role in global reinsurance. See our latest analysis for RenaissanceRe Holdings. While the latest 1 day share price return of 0.76% is softer, the 30 day share price return of 7.59% and year to date share price return of 14.90% sit alongside a 1 year total shareholder return of 34.03%. This may hint...
NYSE:EVEX
NYSE:EVEXAerospace & Defense

Can Eve (EVEX) Turning 50 eVTOL Test Flights Into Certifiable Prototypes Reshape Its Moat?

In April 2026, Eve Air Mobility reported that its full-scale eVTOL engineering prototype has now completed 50 successful test flights since its first flight on December 19, 2025, generating over two hours of high-fidelity performance and systems data as it advances toward certification with Brazil’s aviation authority, ANAC. This milestone underscores Eve’s integrated development approach, combining Embraer-derived aircraft engineering with coordinated planning for operators, cities,...
NasdaqGS:ALKT
NasdaqGS:ALKTSoftware

A Look At Alkami Technology (ALKT) Valuation After New AI And Digital Banking Platform Launches

Alkami Technology (ALKT) has used its Alkami Co:lab 2026 event to roll out a trio of product launches, centering on AI powered development tools, analytics driven engagement, and a unified Digital Sales & Service Platform. See our latest analysis for Alkami Technology. Despite a cluster of AI focused product launches at Alkami Co:lab 2026, Alkami Technology’s 7 day share price return of 8.56% sits against a year to date share price return of 21.74% decline and a 1 year total shareholder...
NYSE:UBER
NYSE:UBERTransportation

Is Uber (UBER) Quietly Rewriting Its Autonomy Strategy With Zagreb Robotaxis And Ace Delivery Push?

Pony.ai announced that its robotaxi program with Verne and Uber has begun commercial service in Zagreb, Croatia, while Uber and Ace Hardware recently revealed a partnership to list more than 3,700 Ace locations on the Uber Eats app across all 50 US states. Alongside these moves, Uber appointed Arjun Kalra as Head of Marketing for India and South Asia, underscoring a push to deepen regional branding and expand into new mobility and retail delivery formats. We'll now examine how Uber's role in...
NasdaqGS:CCBG
NasdaqGS:CCBGBanks

Capital City Bank Group (CCBG) Net Margin Near 25% Reinforces Bullish Earnings Narratives

Capital City Bank Group (CCBG) has just closed out Q4 2025 with total revenue of US$61.5 million and net income of US$13.7 million, translating into basic EPS of US$0.80 as the latest marker of its earnings run into Q1 2026. Over recent quarters the bank has seen revenue move from US$58.5 million in Q3 2024 to US$61.5 million in Q4 2025, while EPS has ranged between roughly US$0.77 and US$0.99, giving investors a clear view of how top line and per share profit have tracked together. Set...
NYSE:KD
NYSE:KDIT

Is Kyndryl (KD) Turning Public-Sector Modernization Into a Durable High-Value Services Advantage?

Earlier in April 2026, Kyndryl announced it was selected by the North Carolina Division of Motor Vehicles to modernize its legacy COBOL-based systems, expand online and mobile services, and host a new environment on Microsoft Azure, while also rolling out new AI-driven offerings like Digital Twin for the Workplace and Sovereignty Solutioning. These moves highlight Kyndryl’s push into complex public-sector modernization and AI-enabled workplace services, reinforcing its role in managing...
NYSE:HLI
NYSE:HLICapital Markets

Houlihan Lokey Wins Special Committee Role In Complex BDC Review

Houlihan Lokey (NYSE:HLI) has been appointed financial advisor to the Special Committee of Investcorp Credit Management BDC, Inc. The mandate covers a review of potential alternatives for Investcorp Credit Management BDC, Inc.'s business. This assignment underscores the firm's role in complex corporate review processes. For investors tracking NYSE:HLI, this new advisory role comes with the stock at a share price of $160.99. The company shows a mixed recent pattern, with a 3.2% return over...
NasdaqGS:LFUS
NasdaqGS:LFUSElectronic

Assessing Littelfuse (LFUS) Valuation After Strong One Year Shareholder Returns

Littelfuse: recent performance snapshot Littelfuse (LFUS) has drawn increased attention after a recent share-price move, with the stock closing at US$395.38. Investors are weighing this level against its recent return profile and current fundamentals. See our latest analysis for Littelfuse. The recent 1.5% one-day share price return and strong 30-day share price return of 23.3% come on top of a 1-year total shareholder return of 156.2%. This indicates powerful momentum rather than a...
NasdaqGS:VSAT
NasdaqGS:VSATCommunications

Why Viasat (VSAT) Is Up 13.3% After New Boeing Antenna Tests And ViaSat-3 F3 Launch Date

Viasat recently entered Boeing’s technical evaluation process for its next-generation AERA electronically steered antenna, while also confirming an April 27, 2026 launch date for its ViaSat-3 F3 satellite aboard a SpaceX Falcon Heavy to expand high-capacity coverage across the Asia-Pacific region. Together, the Boeing evaluation and ViaSat-3 F3 launch timing highlight how Viasat is working to pair advanced in-flight hardware with broader global satellite capacity for commercial, fixed, and...
NYSE:DOW
NYSE:DOWChemicals

Is It Too Late To Consider Dow (DOW) After A 51% Year To Date Surge?

Investors may be wondering if Dow at around US$36.77 is offering good value right now, or if the strong run has already priced in the story. The share price is up 51.5% year to date and 39.6% over the last year, while the past 3 and 5 year returns of 20.7% and 22.3% are weaker. There has also been a recent 7 day move of 8.3% lower and a flat 0.3% return over the last 30 days. Recent coverage of Dow has focused on its role in the wider chemicals sector and how investors are reassessing...
NYSE:DX
NYSE:DXMortgage REITs

Dynex Capital (DX) Net Margin Surge Tests Bearish Cash Flow Concerns

Dynex Capital (DX) has just reported new figures, with recent quarters showing total revenue moving from US$60.3 million in Q4 2024 to US$202.0 million in Q4 2025 and basic EPS shifting from US$0.61 to US$1.17 over the same period, alongside trailing 12 month net income of US$308.9 million. Over the past year, revenue has tracked from US$150.4 million on a trailing basis in Q4 2024 to US$372.1 million by Q4 2025, while trailing EPS has moved from US$1.50 to US$2.49. These figures provide a...
NYSE:IBM
NYSE:IBMIT

Is It Time To Reassess IBM (NYSE:IBM) After Its Recent AI And Cloud Focus?

If you are wondering whether International Business Machines at around US$253.71 is still sensible value or looking stretched, the next sections will unpack what the current price might imply. The stock has returned 6.7% over the last 7 days and 4.9% over the last 30 days, while the year to date return is a 13.0% decline and the 1 year return sits at 10.1%, which gives a mixed picture of recent performance. Over recent months, headlines around International Business Machines have focused on...
NasdaqGS:GRAB
NasdaqGS:GRABTransportation

Can Thailand’s Quick Commerce Shift Reshape Grab’s (GRAB) Super-App Edge in Southeast Asia?

Recent analysis of Thailand’s quick commerce market highlights expanding opportunities for integration into super-apps and omnichannel retail, supporting broader reach, more efficient delivery, and increased use of digital payments across the ecosystem. This evolution could be particularly important for Grab Holdings, as deeper super-app integration and sustainable logistics models in Thailand may strengthen its regional role and operational efficiency over time. We’ll now examine how...
NasdaqGS:RGLD
NasdaqGS:RGLDMetals and Mining

Royal Gold (RGLD) Valuation Check After A Strong 1 Year Run And Recent Share Price Momentum

Royal Gold (RGLD) has drawn fresh attention after a strong month, with the stock up about 23%, even as the past 3 months show a small negative total return for shareholders. See our latest analysis for Royal Gold. With the latest share price at $264.59, Royal Gold’s recent momentum is strong, with a 30 day share price return of 22.95% and a 1 year total shareholder return of 43.56%, supported by multi year total shareholder returns above 100%. If you are gauging how other precious metal names...
NasdaqGS:CDW
NasdaqGS:CDWElectronic

Assessing CDW (CDW) Valuation After Recent Share Price Momentum And Recurring Revenue Focus

CDW (CDW) has drawn fresh attention after a period of mixed share performance, with gains over the past month and past 3 months in contrast to negative total returns over the past year and longer periods. See our latest analysis for CDW. At a share price of $136.85, CDW has seen momentum build in the short term, with a 1 month share price return of 13.79% and a 3 month share price return of 9.69%, while the 1 year total shareholder return of 6.25% decline shows the longer term picture is...
NYSE:CAVA
NYSE:CAVAHospitality

Is CAVA Group’s (CAVA) Glazed Salmon Test Reframing Its Long-Term Menu Innovation Strategy?

CAVA Group has recently opened its first St. Louis-area restaurant in Cottleville, Missouri, while rolling out its new Glazed Salmon menu item nationwide, marking both geographic and product expansion for the Mediterranean fast-casual brand. By pairing rapid entry into the Midwest with its first seafood protein, CAVA is simultaneously testing new markets and broadening its appeal to health-focused diners. We’ll now examine how CAVA’s nationwide Glazed Salmon launch influences the company’s...
NYSE:KRP
NYSE:KRPOil and Gas

A Look At Kimbell Royalty Partners (KRP) Valuation As Recent Momentum Meets Mixed Multiples

Recent performance snapshot Kimbell Royalty Partners (KRP) has drawn attention after a mixed stretch in its unit price, with a small 1 day gain, weaker recent month returns, and stronger performance over the past 3 months and year. See our latest analysis for Kimbell Royalty Partners. The recent 1 day share price gain comes after a softer 7 day and 30 day share price return. However, the 90 day share price return of 15.17% and 1 year total shareholder return of 30.28% point to momentum that...
NYSE:DKS
NYSE:DKSSpecialty Retail

Does DICK'S (DKS) Deeper Push Into Youth Sports Signal A Durable Customer Engagement Edge?

In April 2026, Unrivaled Sports announced landmark partnerships with Under Armour and DICK'S Sporting Goods, making DICK'S the Presenting-Level Sponsor of Ripken Nationals and giving it a premium on-site presence at this high-profile youth baseball championship and related qualifiers. This collaboration embeds DICK'S Sporting Goods more deeply into organized youth sports, potentially strengthening its connection with families and young athletes at the grassroots level. Next, we'll examine...
NasdaqGM:WRD
NasdaqGM:WRDAuto Components

WeRide (WRD) Valuation Check As Aion N60 Milestone Showcases Mass Production ADAS Capabilities

WeRide (WRD) is back in focus after GAC Aion began pre sales for the Aion N60, the first mass produced SUV using WeRide WRD 3.0 ADAS and Qualcomm Snapdragon based autonomous capabilities. See our latest analysis for WeRide. The news around the Aion N60 arrives as WeRide’s share price has climbed to US$8.21, with a 30 day share price return of 29.29% but a year to date share price decline of 12.57% and a 1 year total shareholder return of 2.73% decline. This suggests that recent momentum has...
NasdaqGS:OLMA
NasdaqGS:OLMABiotechs

Olema Pharmaceuticals (OLMA) Is Up 5.6% After Preclinical Data Highlight Deeper ER Blockade Potential

Olema Pharmaceuticals recently reported new preclinical results showing that its oral breast cancer drug palazestrant, alone and with KAT6 inhibitor OP-3136, achieved complete estrogen receptor antagonism and synergistic anti-tumor activity in ER+/HER2- models, with the data presented in posters at the AACR Annual Meeting in San Diego. A key insight is that palazestrant’s direct recruitment of the corepressor NCoR1 and its synergy with OP-3136 could support deeper, more consistent estrogen...
NasdaqGS:PCRX
NasdaqGS:PCRXPharmaceuticals

A Look At Pacira BioSciences (PCRX) Valuation After New EXPAREL Health Economic Data

Pacira BioSciences (PCRX) shares recently reacted to fresh health economic data on its flagship non opioid pain drug, EXPAREL, following presentations at the Academy of Managed Care Pharmacy Annual 2026 Meeting in Nashville. See our latest analysis for Pacira BioSciences. The new EXPAREL health economic data arrives alongside a 90 day share price return of 28.08% and a 30 day share price return of 11.80%. However, the 1 year total shareholder return of 4.56% and 5 year total shareholder...